Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ted Yednock
Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases
International Journal of Toxicology
Toxicology
Related publications
Development of an Anti‐ BAG 3 Humanized Antibody for Treatment of Pancreatic Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis
Open Access Rheumatology: Research and Reviews
Rheumatology
Stem Cells for the Treatment of Neurodegenerative Diseases
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
Potential Therapeutic Effects of Curcumin, the Anti-Inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases
International Journal of Biochemistry and Cell Biology
Biochemistry
Cell Biology
Itolizumab &Ndash; A Humanized Anti-Cd6 Monoclonal Antibody With Better Side Effects Profile for the Treatment of Psoriasis [Corrigendum]
Clinical, Cosmetic and Investigational Dermatology
Dermatology
Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I
Acta Crystallographica Section A: Foundations and Advances
Materials Science
Condensed Matter Physics
Theoretical Chemistry
Biochemistry
Structural Biology
Inorganic Chemistry
Physical
High-Dose Humanized Anti-Il-2 Receptor Alpha Antibody (Daclizumab) for the Treatment of Active, Non-Infectious Uveitis
Journal of Autoimmunity
Allergy
Immunology
Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40
Cancer Research
Cancer Research
Oncology
Development of HER2-specific Humanized Antibody Herceptin (Trastuzumab).
Folia Pharmacologica Japonica
Pharmacology
